Factorytalk co. ltd.
AstraZeneca & Factorytalk Secure Second Consecutive Tulip Greenhouse Award

AstraZeneca has earned Tulip’s prestigious Greenhouse Award for the second year in a row — with Factorytalk once again playing a pivotal role in delivering a scalable digital solution that improved efficiency and standardization across global packing lines.
After winning in 2024 for the Tulip Lifecycle Solution, AstraZeneca continued its momentum in 2025 as the Digital Changeover (DCO) team received Tulip’s prestigious Greenhouse Award — an honor celebrating teams that use Tulip to drive continuous transformation through collaborative problem-solving and user-centric design.
Factorytalk is proud to have played a key role in enabling this achievement, working closely with AstraZeneca to design, validate, and scale a digital changeover solution that transformed operations across global sites.
According to Thomas Foulkes, Associate Director, Digital Projects at AstraZeneca, the challenge, transformation journey, and results highlighted in Tulip’s Greenhouse Spotlight capture the key factors behind the DCO team’s success. The summary below reflects the essential insights he shared.
The Challenge: Packing Line Changeovers Under Pressure
In high-volume pharmaceutical packing operations, changeover time is one of the biggest operational bottlenecks. Many sites relied on paper-based procedures—slow, inconsistent, and lacking visibility. For AstraZeneca, this meant delays, variability, and a lack of standardization across global operations.
The Transformation: From Pilot to Global Rollout in 3 Months
Through close collaboration, AstraZeneca’s DCO team and Factorytalk delivered a scalable, user-centric digital solution on the Tulip platform that meets the stringent needs of pharmaceutical manufacturing.
The Results: Operational Gains and Cultural Shift
With digital changeovers in place, AstraZeneca achieved:
This cultural transformation—including psychological safety, open collaboration, and inclusive co-creation—was a major factor in their Greenhouse Award recognition.
“AstraZeneca’s achievement is a powerful example of what becomes possible when world-class operations meet modern, flexible technology. Our team is proud to have worked side-by-side with AZ to design, build, and validate a global-ready solution at remarkable speed. Scaling from a single pilot to more than 100 lines in three months is not just a technical milestone—it reflects a shared commitment to empowering frontline teams, improving quality, and transforming the way work is done.”
— David Holt, Group Managing Director, Factorytalk
Why Factorytalk & Tulip Made the Difference
Our role in this journey went beyond supplying software. As a trusted partner, Factorytalk:
Thanks to this collaboration, what began as a pilot idea became a global standard — delivered in record time, with measurable improvements in efficiency, standardisation, and organizational culture.
A Shared Success with Global Impact
Factorytalk is honored to support AstraZeneca in advancing digital changeovers across its global operations. This recognition marks not just an award win — but a milestone in how regulated manufacturers can scale modern, human-centric digital solutions with speed and confidence.
For Factorytalk, it reinforces our commitment to helping GMP-regulated organizations achieve agility, standardization, and high performance through proven digital technologies such as Tulip.
For more information about Factorytalk, please visit the company’s website https://www.factory-talk.com/
About Factorytalk
Factorytalk are a leading digital solutions provider and consultancy for the GxP regulated life sciences industries, including pharmaceuticals, biotech, cell and gene therapy, medical device, herbal medicines, health tech, cosmetics, and F&B. Factorytalk has a team of experts operating across Asia, Europe, and the US from their offices in Bangkok, Thailand, and Manchester, UK. The company engages with over 200 customers worldwide and has offered validation, consulting services, and systems implementation for GxP-regulated manufacturing companies, government organizations, and regulators